AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 SEP 26 - (NewsRx.com & NewsRx.net) -- U.S. health officials this fall will reassess hormone replacement therapy for postmenopausal women in response to a recent study questioning the therapy's risks and benefits.
In July 2002, government scientists abruptly ended the nation's biggest study using the hormone combination of estrogen and progestin, saying long-term use significantly increased women's risk of breast cancer, strokes and heart attacks.
The study tested only Prempro, the leading estrogen-progestin combination - not other brands that bear lower doses of estrogen or estrogen skin patches.
The Department of Health and Human Services will hold public forums this fall to consider how the study's results might ...
Source: HighBeam Research, U.S. to re-evaluate hormone replacement therapy's risks.(Brief...